PapersFlow Research Brief
HIV, Drug Use, Sexual Risk
Research Guide
What is HIV, Drug Use, Sexual Risk?
HIV, Drug Use, Sexual Risk refers to the epidemiological intersection of human immunodeficiency virus transmission among injection drug users, influenced by drug injection practices, sexual behaviors, and environmental factors, with interventions like needle exchange programs and respondent-driven sampling to assess and mitigate risks.
This field encompasses 43,409 papers on the global epidemiology of HIV among people who inject drugs, emphasizing harm reduction strategies such as needle exchange programs. Respondent-driven sampling provides a method to study hidden populations like injection drug users, as detailed in 'Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations' by Douglas D. Heckathorn (1997), which has 4208 citations. Chain referral techniques, including snowball sampling, address challenges in accessing these groups, per 'Snowball Sampling: Problems and Techniques of Chain Referral Sampling' by Patrick Biernacki and Dan Waldorf (1981) with 5242 citations.
Topic Hierarchy
Research Sub-Topics
Respondent-Driven Sampling HIV
Methodological advancements in respondent-driven sampling (RDS) for estimating HIV prevalence among hidden populations like injection drug users are studied. Researchers validate RDS estimators and address biases in hard-to-reach networks.
Harm Reduction Injection Drug Use
Evaluations of syringe exchange programs, opioid substitution therapy, and supervised consumption sites assess reductions in HIV transmission. Studies measure behavioral and structural outcomes in diverse settings.
Risk Environment HIV Transmission
Conceptualizes how structural factors like policing, housing instability, and drug markets shape HIV risks among people who inject drugs. Multilevel interventions target modifiable environmental determinants.
HIV Epidemiology Injection Drug Users
Global and regional surveillance tracks HIV incidence, phylogenetic clustering, and co-infections like HCV among PWID. Phylogenetic analyses reveal transmission networks and intervention impacts.
Preexposure Prophylaxis PWID
Clinical trials and implementation studies assess PrEP adherence, efficacy, and integration with harm reduction for people who inject drugs. Research addresses adherence barriers in criminalized settings.
Why It Matters
Needle exchange programs and preexposure prophylaxis (PrEP) reduce HIV transmission risks linked to drug injection and sexual behaviors among high-risk groups. For instance, 'Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men' by Robert M. Grant et al. (2010) demonstrated that oral FTC-TDF provided protection against HIV acquisition, with detectable blood levels correlating strongly with prophylactic effects in a trial funded by the National Institutes of Health (5029 citations). Similarly, 'Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women' by Jared M. Baeten et al. (2012) showed oral TDF and TDF-FTC protected against HIV-1 infection in heterosexuals (3229 citations). These findings support public health interventions in substance abuse clinics, as noted in 'Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings' by Bernard M. Branson et al. (2006), which targets settings including substance abuse treatment clinics (2980 citations). Viral load remains a key predictor of heterosexual transmission, with risks rare below 1500 copies per milliliter, according to 'Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1' by Thomas C. Quinn et al. (2000) (3051 citations).
Reading Guide
Where to Start
'Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations' by Douglas D. Heckathorn (1997), as it introduces a core methodology for studying hidden populations like injection drug users central to this HIV epidemiology field.
Key Papers Explained
'Snowball Sampling: Problems and Techniques of Chain Referral Sampling' by Patrick Biernacki and Dan Waldorf (1981) establishes foundational chain referral techniques, which Douglas D. Heckathorn (1997) in 'Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations' advances with analytical corrections for hidden populations. Robert M. Grant et al. (2010) in 'Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men' applies prophylaxis evidence relevant to overlapping risks, while Jared M. Baeten et al. (2012) in 'Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women' extends it to heterosexual contexts, and Thomas C. Quinn et al. (2000) in 'Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1' links viral factors to transmission dynamics.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Focus on integrating respondent-driven sampling with PrEP trials and viral load monitoring in injection drug user cohorts, as current papers emphasize harm reduction and risk environment impacts without recent preprints available.
Papers at a Glance
Frequently Asked Questions
What is respondent-driven sampling?
Respondent-driven sampling is a method to study hidden populations without a sampling frame, such as injection drug users at risk for HIV. 'Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations' by Douglas D. Heckathorn (1997) describes it as producing low response rates and candid responses via chain referral with analytical adjustments (4208 citations). This approach improves HIV epidemiology studies among people who inject drugs.
How does snowball sampling apply to HIV research among drug users?
Snowball sampling uses chain referral to access hidden groups like injection drug users for HIV studies. 'Snowball Sampling: Problems and Techniques of Chain Referral Sampling' by Patrick Biernacki and Dan Waldorf (1981) explains procedures for qualitative research on deviant behavior, addressing non-self-evident techniques (5242 citations). It aids in overcoming low response rates in hidden populations.
What is the role of PrEP in preventing HIV among high-risk groups?
Preexposure chemoprophylaxis with oral FTC-TDF protects against HIV acquisition in men who have sex with men. 'Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men' by Robert M. Grant et al. (2010) found detectable blood levels strongly correlated with prophylactic effects (5029 citations). Similar protection occurs in heterosexuals via TDF or TDF-FTC, per 'Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women' by Jared M. Baeten et al. (2012) (3229 citations).
How does viral load affect HIV sexual transmission?
Viral load is the chief predictor of heterosexual HIV-1 transmission risk. 'Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1' by Thomas C. Quinn et al. (2000) states transmission is rare below 1500 copies of HIV-1 RNA per milliliter (3051 citations). This informs risk reduction strategies in drug use and sexual contexts.
What are CDC recommendations for HIV testing in substance abuse settings?
Revised HIV testing recommendations apply to health-care providers in substance abuse treatment clinics. 'Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings' by Bernard M. Branson et al. (2006) covers public and private sectors, including emergency departments and urgent care (2980 citations). Testing supports early intervention for injection drug users.
Open Research Questions
- ? How can respondent-driven sampling be optimized to better estimate HIV prevalence in injection drug user networks under varying risk environments?
- ? What are the long-term effects of combining needle exchange programs with PrEP on HIV incidence among people who inject drugs?
- ? In what ways does the risk environment modify the relationship between viral load and HIV transmission in drug-using populations?
- ? How effective are chain referral methods compared to probability sampling for capturing sexual risk behaviors in hidden HIV-affected groups?
Recent Trends
The field maintains 43,409 works with no specified 5-year growth rate; foundational papers like 'Snowball Sampling: Problems and Techniques of Chain Referral Sampling' (1981, 5242 citations) and 'Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations' (1997, 4208 citations) continue high citation rates, underscoring persistent reliance on chain referral methods for HIV epidemiology among injection drug users.
Research HIV, Drug Use, Sexual Risk with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching HIV, Drug Use, Sexual Risk with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers